Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Black Diamond Therapeutics Inc
NASDAQ:BDTX
Black Diamond Therapeutics Inc
NASDAQ:BDTX
Price:
1.66
USD
-12.63%
Market Closed
Market Cap:
$95.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Black Diamond Therapeutics Inc
NASDAQ:BDTX
|
US |
|
Airports of Thailand PCL
OTC:APTPF
|
TH |
|
F
|
Ford Motor Co
F:FMC1
|
US |
|
F
|
Ford Motor Co
BMV:F
|
US |
|
F
|
Ford Motor Co
XMUN:FMC1
|
US |
Wall St Price Targets
BDTX Price Forecast
Based on 8 analysts
Based on 8 analysts
+545% Upside
from
$1.66
today
Black Diamond Therapeutics Inc (BDTX)’s 12-month stock price forecast through November 2027 has a consensus target of $10.71, implying 545% upside. The forecast is based on price targets from 8 Wall Street analysts.
BDTX Analyst Rating
Based on 8 analysts
Based on 8 analysts
Analysts rate BDTX Strong buy, with 7 of 8 recommending Buy or Strong buy.
Black Diamond Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BDTX's stock price target?
Price Target
10.71
USD
10.71
USD
According to Wall Street analysts, the average 1-year price target for BDTX is 10.71 USD with a low forecast of 8.08 USD and a high forecast of 14.7 USD.
What is the Revenue forecast for Black Diamond Therapeutics Inc?
Projected CAGR
27%
27%
The compound annual growth rate for Revenue over the next 8 years is 27%.
What is the Operating Income forecast for Black Diamond Therapeutics Inc?
Projected CAGR
36%
36%
The compound annual growth rate for Operating Income over the next 8 years is 36%.
What is the Net Income forecast for Black Diamond Therapeutics Inc?
Projected CAGR
29%
29%
The compound annual growth rate for Net Income over the next 8 years is 29%.
